Provectus Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.007; its P/E ratio is -26.22; Provectus Pharmaceuticals is scheduled to report earnings on May 9, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 69.70K	$ 161.84K	$ 205.03K	$ 164.84K	$ 0.00
Gross Profit	$ 69.73K	$ 161.84K	$ 205.03K	$ 164.84K	-
EBIT	$ -714.32K	$ -784.24K	$ 1.19M	$ -683.72K	$ -666.83K
EBITDA	$ -712.09K	$ -782.01K	$ 1.19M	$ -681.68K	$ -664.01K
Net Income Common Stockholders	$ -775.80K	$ -835.06K	$ 1.15M	$ -732.65K	$ -713.27K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 367.25K	$ 1.36M	$ 1.32M	$ 1.43M	$ 67.03K
Total Assets	$ 1.69M	$ 1.69M	$ 1.72M	$ 2.04M	$ 2.05M
Total Debt	$ 937.93K	$ 319.48K	$ 837.16K	$ 2.18M	$ 2.72M
Net Debt	$ 570.68K	$ -1.04M	$ -484.29K	$ 752.99K	$ 2.65M
Total Liabilities	$ 9.21M	$ 8.98M	$ 8.72M	$ 8.27M	$ 8.91M
Stockholders Equity	$ -7.52M	$ -7.30M	$ -7.00M	$ -6.23M	$ -6.86M
Cash Flow	-
Free Cash Flow	$ -768.87K	$ -628.51K	$ -613.38K	$ -754.79K	$ -816.58K
Operating Cash Flow	$ -768.87K	$ -628.51K	$ -613.38K	$ -754.79K	$ -816.58K
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	$ 817.86K	$ 656.44K	$ 515.70K	$ 474.16K	$ 496.87K

Currency in USD

Provectus Pharmaceuticals Earnings and Revenue History

Income Statement >

Provectus Pharmaceuticals Debt to Assets

Balance Sheet >

Provectus Pharmaceuticals Cash Flow

Cash Flow >

Provectus Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing